Oversea-Chinese Banking Corp (OCBC)
TEVA icon

Oversea-Chinese Banking Corp (OCBC)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,651
Closed -$109K – 398
2023
Q3 		$109K Hold
10,651
– – ﹤0.01% 370
2023
Q2 		$80.2K Hold
10,651
– – ﹤0.01% 321
2023
Q1 		$94.3K Sell
10,651
-68,496
-87% -$677K ﹤0.01% 314
2022
Q4 		$722K Buy
+79,147
New +$691K 0.04% 186

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Slate Path Capital
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s TEVA Position: Q4 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2023, closing a stake of 10,651 shares — an estimated $109K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in TEVA in Q4 2022 and held it in 4 quarters. The position peaked at $722K in Q4 2022. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 10,651 Teva Pharmaceutical Industries Limited shares in Q4 2023, an estimated $109K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Teva Pharmaceutical Industries Limited in Q4 2022 and held it in 4 quarters.
  • Oversea-Chinese Banking Corp (OCBC)'s Teva Pharmaceutical Industries Limited position peaked at $722K in Q4 2022.
  • 447 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q4 2023, filed 1 Feb 2024.